Search results for " chronic"

showing 10 items of 1458 documents

A sense of belonging: A meta-ethnography of the experience of patients with chronic obstructive pulmonary disease receiving care through telemedicine.

2019

To synthesize the qualitative research in the literature addressing how patients with chronic obstructive pulmonary disease experience care received by telemedicine.Meta-ethnography.Twelve studies, published from 2013 - 2018, were identified by a search of relevant systematic databases in June 2017, including updated searches performed in June 2018.The studies were reviewed and critically appraised independently by three researchers. The review followed the seven steps of meta-ethnography developed by Noblit and Hare, including a line-of-argument synthesis.The synthesis revealed three second-order constructs: presence, transparency, and ambivalence. Using a line-of-argument synthesis, a mod…

medicine.medical_specialtyTelemedicinePsychological interventionPulmonary diseaseNurse–client relationshipSense of belonging03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicinemedicineHumans030212 general & internal medicineIntensive care medicineGeneral NursingAnthropology CulturalQualitative ResearchCOPD030504 nursingbusiness.industryBelongingnessmedicine.diseaseTelemedicinePatient Satisfaction0305 other medical sciencebusinessQualitative researchJournal of advanced nursingREFERENCES
researchProduct

Interferon decreases serum lipid peroxidation products of hepatitis C patients

1994

Abstract Thiobarbituric acid reactive substances (TBARS) concentration in serum has been determined in healthy subjects and in patients suffering acute hepatitis and chronic cases of hepatitis C. Treatment with interferon of the chronic active hepatitis C patients, 5 × 10 6 U three times a week during 2 months, led in those patients whose SGPT activity normalized in serum, to a concomitant decrease in serum TBARS content. The possible theoretical involvement of peroxidation and antioxidants in this beneficial effect of interferon in hepatitis C patients is discussed. The results presented confirm the value of TBARS as laboratory test in the management of liver diseases and as a useful tool …

medicine.medical_specialtyThiobarbituric acidHIV InfectionsThiobarbituric Acid Reactive SubstancesBiochemistryGastroenterologyHepatitisLipid peroxidationchemistry.chemical_compoundInterferonPhysiology (medical)Internal medicineTBARSHumansMedicineIn patientHepatitis ChronicHepatitisSuperoxide Dismutasebusiness.industryHepatitis Cmedicine.diseaseHepatitis CLipidschemistryConcomitantAcute DiseaseImmunologyInterferonsLipid Peroxidationbusinessmedicine.drugFree Radical Biology and Medicine
researchProduct

A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis

2003

The most relevant randomized controlled trials of interferon-alpha (IFN) for naive patients with chronic hepatitis C (CHC) published in a decade, just before appearance of pegylated IFN trials in 2000, were included in this paper. Its purpose is to review the relationship between sustained biochemical response in active versus control group versus usual clinical variables as IFN regimens, cirrhosis, genotype and versus less frequently addressed variables as funding, methodological quality or location of principal author. Meta-analysis estimates of global treatment effect varied according to trial design: group 1=IFN versus placebo/no treatment, 32 RCTs, 2499 pts, OR 9.5 (6.3-14.2); group 2a…

medicine.medical_specialtyTime FactorsinteractionAlpha interferonSubgroup analysisLogistic regressionPlaceborandom effects modellaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicinemeta-regressionmedicineHumansPharmacology (medical)Meta-regressionInterferon alfaRandomized Controlled Trials as Topicbusiness.industrylogistic regressionRibavirinInterferon-alphaGeneral MedicineHepatitis C ChronicLogistic ModelsTreatment OutcomechemistryImmunologyfixed effects modelbusinessmedicine.drugContemporary Clinical Trials
researchProduct

Learning curve for piezosurgery in well-trained otological surgeons

2009

Abstract Objective Piezosurgery is an ultrasound instrument (24.7-29.5 kHz) capable of cutting bone without necrosis and nonmineralized tissue damage. The aim of this work has been to determine the time required for a well-trained surgeon to perform otological surgery with the piezoelectric device. Study Design Case series with planned data collection. Sixty-three patients affected by otosclerosis and 63 by chronic otitis media were enrolled. For each disease, patients were divided into three numerically equal groups, with each group assigned to a well-trained otological surgeon. Patients underwent stapedotomy (n = 63) and intact canal wall tympanoplasty (n = 63) with the piezoelectric devi…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentUltrasonic TherapypiezosurgeryOtoacoustic emissionOsteotomyotologic surgerymedicineTrainingHumanspiezosurgery otologic surgeryChronic otitis mediaPiezosurgeryPiezosurgery; Otosclerosis; Chronic otitis media; Training; Surgerymedicine.diagnostic_testbusiness.industrypiezosurgery; otologic surgeryUltrasoundEquipment DesignTympanometryTympanoplastymedicine.diseaseSurgeryOtitis MediaSettore MED/31 - OtorinolaringoiatriaOtosclerosisOtorhinolaryngologyOtosclerosisSurgeryAudiometrybusiness
researchProduct

AISF position paper on HCV in immunocompromised patients.

2018

Abstract This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

medicine.medical_specialtyTransplant RecipientComorbidityAntiviral AgentsOrgan transplantation03 medical and health sciencesImmunocompromised Host0302 clinical medicineInternal medicineNeoplasmsmedicineImmunocompromised patientHumansChronicIntensive care medicineAntiviral AgentHepatologybusiness.industryGastroenterologyHepatologyHepatitis C Chronicmedicine.diseaseComorbidityHepatitis COrgan transplantHCV; Immunocompromised patients; Organ transplant; Hepatology; GastroenterologyTransplant RecipientsHCV; Immunocompromised patients; Organ transplant; Antiviral Agents; Comorbidity; Hepatitis C Chronic; Humans; Immunocompetence; Italy; Neoplasms; Transplant Recipients; Immunocompromised HostItaly030220 oncology & carcinogenesisHCVHCV Immunocompromised patients Organ transplantPosition paperNeoplasmImmunocompromised patients030211 gastroenterology & hepatologyImmunocompetencebusinessImmunocompetenceDirect actingHumanDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis

2018

Fulvio Braido,1 Pierachille Santus,2 Angelo Guido Corsico,3 Fabiano Di Marco,4 Giovanni Melioli,5 Nicola Scichilone,6 Paolo Solidoro7 1Department of Internal Medicine, IRCCS San Martino di Genova University Hospital, Genoa, Italy; 2Department of Biomedical and Clinical Sciences, University of Milan, Division of Respiratory Diseases, “L. Sacco” University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy; 3Department of Internal Medicine and Therapeutics, Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy; 4Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy; 5Center for Precision Medici…

medicine.medical_specialtyValidation studyConcordance analysisbusiness.industryGeneral MedicinePrimary careInternational Journal of Chronic Obstructive Pulmonary Diseasemedicine.diseasecomputer.software_genreObstructive lung diseaseExpert system03 medical and health sciences0302 clinical medicine030228 respiratory systemSample size determinationConcomitantEmergency medicinemedicine030212 general & internal medicineMedical diagnosisbusinesscomputerInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban

2015

Renal insufficiency increases the risk of stroke and bleeding in atrial fibrillation patients. Although vitamin K antagonists reduce the risk of stroke in patients with moderate renal dysfunction, this observation is less clear in patients with renal impairment. Moreover, the risk of bleeding with vitamin K antagonists increases as renal function worsens. Maintaining international normalized ratio values within therapeutic targets is more difficult in patients with renal dysfunction, and those agents may cause warfarin-related nephropathy and vascular calcification. Rivaroxaban is the only nonvitamin K oral anticoagulant with a dose specifically tested in patients with moderate renal insuff…

medicine.medical_specialtyVitamin Kmedicine.drug_classRenal functionurologic and male genital diseasesNephropathyRivaroxabanInternal medicineAtrial FibrillationmedicineHumansRenal Insufficiency ChronicStrokeAgedRivaroxabanbusiness.industryHealth PolicyWarfarinAnticoagulantsAtrial fibrillationVitamin K antagonistmedicine.diseaseStrokeCardiologyWarfarinbusinessFactor Xa Inhibitorsmedicine.drugKidney diseaseJournal of Comparative Effectiveness Research
researchProduct

Treatment of chronic hepatitis C in hemodialysis patients

2008

Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the dialysis unit. Management of chronic hepatitis C is also more complicated in hemodialysis patients because of altered pharmacokinetics and a predisposition for drug-related toxicity, particularly ribavirin-induced anemia. Clinical trials of patients with chronic hepatitis C and healthy, functioning kidney grafts are rare because of the inherent dangers of graft rejection. As a result, most studies…

medicine.medical_specialtyWaiting ListsHepatitis C virusmedicine.medical_treatmentPopulationInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundRenal DialysisInternal medicinePrevalencemedicineHumanseducationInterferon alfaeducation.field_of_studyHepatologybusiness.industryRibavirinInterferon-alphavirus diseasesHepatitis CHepatitis C ChronicHepatologymedicine.diseaseKidney TransplantationRecombinant Proteinsdigestive system diseasesSurgeryTolerabilitychemistryKidney Failure ChronicHemodialysisbusinessmedicine.drugHepatology
researchProduct

Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

2021

Aging with multimorbidity and polytherapy are the most significant factors that could led to inappropriate prescribing of contraindicated medications in patients with chronic kidney disease (CKD). The aim of this study was to evaluate the prescriptions of contraindicated drugs in older adults in CKD and to identify their associated factors in a hospital context. An observational retrospective study was carried out considering all patients ≥65 years with at least one serum creatinine value recorded into the REPOSI register into 2010–2016 period. The estimated glomerular filtration rate (eGFR) was applied to identify CKD. A descriptive analysis was performed to compare demographic and clinica…

medicine.medical_specialtyappropriateness of prescriptionprescribing patternsRenal functionContext (language use)RM1-950Logistic regressionNOchemistry.chemical_compoundolder patientInternal medicinehospital settingmedicinePharmacology (medical)LS4_4Medical prescriptionprescribing patternappropriateness of prescriptions chronic kidney disease hospital setting older patients prescribing patterns real-world data.Original ResearchPharmacologyCreatininereal-world databusiness.industryRetrospective cohort studymedicine.diseaseolder patientsreal-world data.appropriateness of prescriptions; chronic kidney disease; hospital setting; older patients; prescribing patterns; real-world dataappropriateness of prescriptionschemistryObservational studyTherapeutics. Pharmacologybusinesschronic kidney diseaseKidney diseaseFrontiers in Pharmacology
researchProduct

Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept

2010

Abstract During past decades the relationship between dentistry and internal medicine and especially the concept of the so-called focal infection theory have long been a matter of debate. The pathogenesis of focal diseases has been classically attributed to dental pulp pathologies and periapical infections. Nonetheless, in recent years, their role is being dismissed while increasing interest is being devoted to the possible associations between periodontal infection and systemic diseases. In fact, periodontal pathogens and their products, as well as inflammatory mediators produced in periodontal tissues, might enter the bloodstream, causing systemic effects and/or contributing to systemic d…

medicine.medical_specialtybusiness.industryDentistryInflammationDiseasePeriodontologySystemic inflammationFocal infection theorymedicine.diseaseChronic periodontitisdental focal infection chronic periodontitis periodontics dentistry internal medicine inflammationRisk FactorsSettore MED/28 - Malattie OdontostomatologicheInternal medicineDentistryChronic DiseaseChronic PeriodontitismedicineInternal MedicineHumansBacterial antigenRisk factormedicine.symptombusiness
researchProduct